Among the adverse effects of statins, which is the most common reason for discontinuation or dose reduction in clinical practice?

Explanation

## Most Common Adverse Effect of Statins Leading to Discontinuation ### Incidence and Clinical Significance **Key Point:** Muscle pain and myalgia (statin-associated muscle symptoms, SAMS) is the most frequent adverse effect reported by statin users and the leading cause of dose reduction or discontinuation in clinical practice, occurring in 5–10% of patients on therapy. ### Statin-Associated Muscle Symptoms (SAMS) | Feature | Myalgia | Myositis | Rhabdomyolysis | |---------|---------|----------|----------------| | **Incidence** | 5–10% | <1% | <0.1% | | **CK elevation** | Normal or mild | >3× ULN | >10× ULN | | **Myoglobinuria** | No | Rare | Yes | | **Renal failure** | No | Rare | Yes | | **Reversibility** | Yes (on stopping) | Yes | May persist | | **Reason for D/C** | Most common | Uncommon | Rare | **High-Yield:** Myalgia accounts for the majority of statin-related discontinuations because: 1. **Frequency** — occurs in 5–10% of statin users 2. **Symptom burden** — muscle pain, weakness, fatigue reduce quality of life 3. **Reversibility** — symptoms resolve within days to weeks of stopping the statin 4. **Patient perception** — patients often attribute any muscle symptoms to the statin and request discontinuation ### Mechanism of SAMS - Depletion of ubiquinone (CoQ~10~) in mitochondria - Impaired ATP production in muscle cells - Increased oxidative stress and inflammation - Statin-induced autophagy in muscle fibres ### Clinical Pearl **Statin-Induced Muscle Injury Spectrum:** Most patients experience mild myalgia (5–10%), a smaller subset develop myositis with CK elevation (0.1–1%), and true rhabdomyolysis with acute kidney injury is rare (<0.1%). The vast majority of discontinuations are due to myalgia, not severe myositis or rhabdomyolysis. ### Management of SAMS 1. **Dose reduction** — often sufficient to relieve symptoms while maintaining LDL benefit 2. **Statin switching** — pravastatin or rosuvastatin may be better tolerated 3. **Intermittent dosing** — alternate-day or twice-weekly dosing reduces symptoms 4. **CoQ~10~ supplementation** — modest evidence; may help some patients 5. **Continuation with monitoring** — many patients tolerate symptoms and continue therapy **Mnemonic:** **SAMS** — Statin-Associated Muscle Symptoms (the most common reason for statin discontinuation).